Replies to post #3031 on OrganiGram Holdings Inc (OGI)

[john1311]

Brown singles out two companies in his coverage universe that he feels have the most upside, on a relative basis. The analyst says OrganiGram (TSXV:OGI) and Supreme Pharma (TSXV:SL) are both buys. He has a target of $4.20 on the former, which closed Friday at $2.60, and a target of $2.10 on the latter, which closed Friday at $1.70.


http://www.cantechletter.com/2017/02/canopy-growth-corp-still-20-upside-says-echelon-wealth/